SCHEMBL1185759

SCHEMBL1185759

O=C1CCNC(=O)CN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL575814 1.00 CRBN (0.65)
SCHEMBL27172945 1.00 CRBN (0.65)
SCHEMBL21978874 0.88 CRBN (0.56)
SCHEMBL6365823 0.87 CRBN (0.85)
SCHEMBL16431244 0.83 OR51E2 (0.79)
SCHEMBL21473988 0.83 OR51E2 (0.79)
SCHEMBL24827100 0.80 CRBN (0.47)
SCHEMBL42430 0.80
Diketopiperazine SCHEMBL66638 0.80
SCHEMBL23975525 0.80 CRBN (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090104116-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF JERINI AG (DE) 2009-04-23 US claimed
EP-1979342-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF Jerini AG (DE) 2008-10-15 EP claimed
WO-2007088041-A1 COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF JERINI AG (DE) 2007-08-09 WO claimed
CN-116785449-A Benzopyrrolopyrrole heterocyclic compound and conjugate thereof, preparation method and application thereof 江苏恒瑞医药股份有限公司 2023-09-22 CN disclosed
EP-2805732-B1 Polymer-drug conjugates for the treatment of amyloidosis FUNDACIÓN COMUNIDAD VALENCIANA CT DE INVESTIGACIÓN PRINCIPE FELIPE (ES) 2016-09-28 EP disclosed
US-20160114055-A1 POLYMER DRUG CONJUGATES FOR THE TREATMENT OF AMYLOIDOSIS FUNDACION DE LA COMUNIDAD VALENCIANA "CENTRO DE INVESTIGACIONES PRINCIPE FELIPE" (ES) 2016-04-28 US disclosed
EP-2518056-B1 SEVEN-MEMBERED RING COMPOUND AND PHARMACEUTICAL USE THEREFOR DAIICHI SANKYO CO LTD (JP) 2015-07-29 EP disclosed
US-9040701-B2 Apaf-1 inhibitor compounds LABORATORIOS SALVAT, S.A. (ES) 2015-05-26 US disclosed
US-8927534-B2 Compounds for the inhibition of integrins and use thereof SHIRE ORPHAN THERAPIES GMBH (DE) 2015-01-06 US disclosed
EP-2805732-A1 Polymer-drug conjugates for the treatment of amyloidosis Fundación Comunidad Valenciana Centro de Investigación Principe Felipe (ES) 2014-11-26 EP disclosed
US-8846660-B2 Seven-membered ring compound and pharmaceutical use therefor DAIICHI SANKYO COMPANY, LTD. (JP) 2014-09-30 US disclosed
US-20060189591-A1 Five-membered heterocyclic derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
US-20060128685-A1 Pyrazole derivative DAIICHI PHARMACEUTICAL CO., LTD., (JP) 2006-06-15 US disclosed
EP-1621537-A1 FIVE-MEMBERED HETEROCYCLIC DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-02-01 EP disclosed
EP-1591443-A1 PYRAZOLE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-11-02 EP disclosed
CN-1178923-C 1, 4-diazepan-2, 5-dione derivatives and their use as NK-1 receptor antagonists - 2004-12-08 CN disclosed
EP-1472377-A2 GENETIC POLYMORPHISMS IN THE PREPROTACHYKININ GENE F. HOFFMANN-LA ROCHE AG (CH) 2004-11-03 EP disclosed
US-20030158187-A1 Isolated nucleic acids, a diagnostic kit, sequence identification, gene sequence determination, a computer program with stored sequence information F. HOFFMANN-LA ROCHE AG A SWISS COMPANY (CH) 2003-08-21 US disclosed
WO-2003064685-A2 GENETIC POLYMORPHISMS IN THE PREPROTACHYKININ GENE F. HOFFMANN-LA ROCHE AG (CH) 2003-08-07 WO disclosed
CN-1430611-A 1, 4-diazepan-2, 5-dione derivatives and their use as NK-1 receptor antagonists HOFFMANN LA ROCHE (CH) 2003-07-16 CN disclosed